Cargando…
Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study
Chronic gastro-duodenal reflux in the esophagus is a major risk for intestinal metaplasia and Barrett’s adenocarcinoma. A role for chronic use of proton pump inhibitor (PPI) in the increased incidence of esophageal adenocarcinoma in Western countries has been previously suggested. The aim of this wo...
Autores principales: | Dall’Olmo, Luigi, Fassan, Matteo, Dassie, Elisa, Scarpa, Marco, Realdon, Stefano, Cavallin, Francesco, Cagol, Matteo, Battaglia, Giorgio, Pizzi, Marco, Guzzardo, Vincenza, Franceschinis, Erica, Pasut, Gianfranco, Rugge, Massimo, Zaninotto, Giovanni, Realdon, Nicola, Castoro, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240576/ https://www.ncbi.nlm.nih.gov/pubmed/25415190 http://dx.doi.org/10.1371/journal.pone.0112862 |
Ejemplares similares
-
CD80 expression promotes immune surveillance in Barrett’s metaplasia
por: Scarpa, Melania, et al.
Publicado: (2019) -
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
por: Fassan, Matteo, et al.
Publicado: (2016) -
PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
por: Fassan, Matteo, et al.
Publicado: (2019) -
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis
por: Fassan, Matteo, et al.
Publicado: (2014) -
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia
por: Fassan, Matteo, et al.
Publicado: (2013)